All Pathways
UrologyEmergency

Epididymo-orchitis Management (EAU 2024)

Epididymo-orchitis Management (EAU 2024): Acute Scrotal Pain - Suspect Epididymo-orchitis → ⚠️ FIRST: Rule Out Testicular Torsion → Clinical Assessment ...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Acute Scrotal Pain - Suspect Epididymo-orchitis

    Gradual onset scrotal pain, swelling, fever

    1. Warning

      ⚠️ FIRST: Rule Out Testicular Torsion

      Torsion is surgical emergency - must exclude

      • Sudden onset (vs gradual in epididymitis)
      • Age: torsion common in adolescents
      • Absent cremasteric reflex suggests torsion
      • Nausea/vomiting more common with torsion
      • If ANY doubt: Doppler US or surgical exploration
      • Prehn sign NOT reliable for differentiation
      1. Action

        Clinical Assessment

        History and examination

        • Gradual onset (hours to days)
        • Epididymal tenderness (posterior testis)
        • Scrotal erythema, swelling, warmth
        • Fever, dysuria, urethral discharge
        • Sexual history (STI risk assessment)
        • Urinary symptoms, recent instrumentation
        1. Action

          Doppler Ultrasound

          Confirm diagnosis, rule out abscess

          • Increased blood flow to epididymis (vs absent in torsion)
          • Enlarged, heterogeneous epididymis
          • May see reactive hydrocele
          • Rule out abscess formation
          • Testicular involvement = orchitis
          1. Decision

            Likely Pathogen?

            Based on age and risk factors

            1. Action

              STI-Related (Age <35, Sexual Risk)

              Chlamydia, Gonorrhea most common

              • Sexually active men <35 years
              • Urethral discharge present
              • Recent new partner
              • NAAT for Chlamydia/Gonorrhea
              • Urethral swab if discharge
              • Test/treat partner
              1. Action

                STI Treatment Regimen (EAU 2024)

                Cover Chlamydia AND Gonorrhea

                • Ceftriaxone 500mg IM x1 dose
                • PLUS Doxycycline 100mg PO BID x10-14 days
                • Alternative: Azithromycin 1g PO x1 if compliance concern
                • Partner notification and treatment
                • Test of cure if persistent symptoms
                • Screen for HIV, syphilis, hepatitis
                1. Action

                  Supportive Care

                  Symptom management

                  • Scrotal elevation and support
                  • NSAIDs (ibuprofen 400-600mg TID)
                  • Ice packs (wrapped, 20 min intervals)
                  • Rest, avoid strenuous activity
                  • Hydration
                  • Sexual abstinence until treatment complete
                  1. Decision

                    Abscess or No Improvement?

                    After 48-72 hours of treatment

                    1. Action

                      Follow-Up Care

                      Monitor resolution

                      • Re-evaluate at 48-72 hours
                      • Clinical improvement expected
                      • Complete antibiotic course
                      • Repeat US if concern for abscess
                      • Urology referral if recurrent
                      • Evaluate for structural abnormality
                      1. Outcome

                        Expected Outcomes

                        Good prognosis with treatment

                        • Full resolution with appropriate antibiotics
                        • Swelling may persist for weeks
                        • Chronic epididymitis in ~15%
                        • Infertility risk if bilateral/severe
                        • Recurrence: evaluate for underlying cause
                    2. Action

                      Abscess Management

                      Surgical consideration

                      • Percutaneous drainage if accessible
                      • Surgical drainage/exploration
                      • Epididymectomy if severe/necrotic
                      • Orchiectomy if testis non-viable
                      • IV antibiotics
                      • Prolonged course
            2. Action

              Enteric Organisms (Age >35, No STI Risk)

              E. coli, Pseudomonas, Enterococci

              • Older men (>35 typically)
              • Associated UTI symptoms
              • Recent urinary instrumentation
              • BPH with obstruction
              • Urine culture and sensitivity
              • Consider structural evaluation
              1. Action

                Enteric Organism Treatment (EAU 2024)

                Fluoroquinolone or TMP-SMX

                • Levofloxacin 500mg PO daily x10-14 days
                • OR Ciprofloxacin 500mg PO BID x10-14 days
                • OR TMP-SMX DS PO BID x10-14 days
                • Adjust based on culture results
                • Duration: 2-4 weeks for severe cases
                • Consider prostate involvement

Guideline Source

EAU Guidelines on Urological Infections 2024

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Must rule out testicular torsion if any doubt
  • Does not address tuberculous epididymitis in detail
  • Pediatric epididymitis may have viral etiology
  • Chronic epididymitis requires different approach
  • Local antibiotic resistance patterns should guide therapy

Applicable Regions

USEUUKAU

AU: Australian STI guidelines concordant

EU: EAU 2024 - primary European guideline

UK: BASHH guidelines for STI-related, similar to EAU

US: CDC STI guidelines concordant with EAU for STI-related cases

Version 1Next review: 2028-01-11

Frequently Asked Questions

What is the Epididymo-orchitis Management (EAU 2024)?

The Epididymo-orchitis Management (EAU 2024) is a emergency clinical algorithm for Urology. It provides a structured decision tree to guide clinical decision-making, based on EAU Guidelines on Urological Infections 2024.

What guideline is the Epididymo-orchitis Management (EAU 2024) based on?

This algorithm is based on EAU Guidelines on Urological Infections 2024 (DOI: 10.1016/j.eururo.2024.03.035).

What are the limitations of the Epididymo-orchitis Management (EAU 2024)?

Known limitations include: Must rule out testicular torsion if any doubt; Does not address tuberculous epididymitis in detail; Pediatric epididymitis may have viral etiology; Chronic epididymitis requires different approach; Local antibiotic resistance patterns should guide therapy. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Epididymo-orchitis Management (EAU 2024) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free